PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Nov-2024 Jaguar Health Reports Third Quarter 2024 Financial Results AccessWire
13-Nov-2024 Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology Immunic AG
13-Nov-2024 EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024 EAACI
13-Nov-2024 Sanofi wins appeal against negative Final Draft Guidance for its standard-of-care multiple myeloma combination therapy opening the door for a third NICE Committee Meeting Sanofi
13-Nov-2024 Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial with ORX750, a Novel Orexin Receptor 2 (OX2R) Agonist Nxera Pharma
13-Nov-2024 Survey: Unsustainable Regulatory Workloads Leave No Choice About AI Adoption ArisGlobal
13-Nov-2024 Sanofi wins appeal against negative Final Draft Guidance for its standard-of-care multiple myeloma combination therapy opening the door for a third NICE Committee Meeting Sanofi
13-Nov-2024 TrakCel sets new standards for the safe, effective, and efficient administration of cell & gene therapies TrakCel
13-Nov-2024 New Study from Lindus Health Finds Patients are More Likely to Join a Clinical Trial with Telehealth Care Lindus Health
13-Nov-2024 CAS and Deloitte China announce a strategic collaboration to empower clients with market insights and scientific innovation expertise CAS
13-Nov-2024 Bioz Partnership Empowers PurePEG to Showcase Product Use-Cases From Within Scientific Publications AccessWire
13-Nov-2024 Eckert & Ziegler and Telix Pharmaceuticals Enter into a Collaboration and Licence Agreement for Actinium-225 Eckert & Ziegler SE
13-Nov-2024 ANGLE presents two posters at EACR AccessWire
12-Nov-2024 Theralase(R) Extends Warrants AccessWire
12-Nov-2024 Ensysce Biosciences Reports Third Quarter 2024 Financial Results AccessWire
12-Nov-2024 Lifeloc Reports Third Quarter 2024 Results AccessWire
12-Nov-2024 Xtant Medical Reports Third Quarter 2024 Financial Results AccessWire
12-Nov-2024 Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event AccessWire
12-Nov-2024 Cosmos Health Issues Letter to Shareholders AccessWire
12-Nov-2024 Pentixapharm Releases Interim Report for the Third Quarter of 2024 Pentixapharm Holding AG